Celecoxib Impurity 29 (Moxifloxacin Impurity 13)

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB163266022
CAS	163266-02-2
Molecular Weight	230.19
Molecular Formula	C11H9F3O2

What is the product name of CAS 163266-02-2?

The product name is Celecoxib Impurity 29 (Moxifloxacin Impurity 13).

What is the molecular weight of Celecoxib Impurity 29 (Moxifloxacin Impurity 13)?

The molecular weight is 230.19.

What is the molecular formula of Celecoxib Impurity 29 (Moxifloxacin Impurity 13)?

The molecular formula is C11H9F3O2.

What is the chemical structure of Celecoxib Impurity 29 (Moxifloxacin Impurity 13)?

The chemical structure is composed of 11 carbon atoms, 9 hydrogen atoms, 3 fluorine atoms, and 2 oxygen atoms.

What is the significance of identifying Celecoxib Impurity 29 (Moxifloxacin Impurity 13)?

Identifying impurities in pharmaceutical products is crucial for ensuring the safety and efficacy of drugs.

How does the presence of Celecoxib Impurity 29 (Moxifloxacin Impurity 13) affect the quality of Celecoxib or Moxifloxacin?

The presence of impurities can impact the purity, stability, and efficacy of the active pharmaceutical ingredients.

Are there specific methods recommended for detecting Celecoxib Impurity 29 (Moxifloxacin Impurity 13)?

Analytical techniques such as HPLC, GC-MS, and NMR spectroscopy can be used to detect and quantify impurities.

Is Celecoxib Impurity 29 (Moxifloxacin Impurity 13) considered a toxic impurity?

The toxicity of an impurity depends on its concentration and profile, so it is essential to determine the level of impurities present.

How can pharmaceutical manufacturers control the levels of Celecoxib Impurity 29 (Moxifloxacin Impurity 13) in their products?

Manufacturers can implement quality control measures, use high-quality raw materials, and optimize production processes to minimize impurity formation.

Can the presence of Celecoxib Impurity 29 (Moxifloxacin Impurity 13) impact the bioavailability of the active ingredient?

Impurities can potentially affect the bioavailability and pharmacokinetics of the drug, so monitoring and controlling impurity levels are critical for ensuring drug safety and efficacy.

* Products or Services Interested: Celecoxib Impurity 29 (Moxifloxacin Impurity 13) (163266-02-2)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry